futibatinib
otsuka
['futibatinib', 'taiho']
taiho oncology announces updated efficacy and safety data for futibatinib in cholangiocarcinoma at 2022 asco annual meeting #stocksmarket #pressrelease
Join us at https://t.co/9QZSYoqhvl - Stock Market News and Press Releases. #StockMarket - As an affiliate, we earn from qualifying purchases.